Surgical eye robot performs precision-injection
Procedure shows that it is technically possible to safely dissolve a blood clot from the retinal vein with robotic support


Colin Kerr
Published: Thursday, January 26, 2017

A Phase 2 trial now has to show what the clinical effect is for patients with retinal vein occlusion"The operation was successful and is a first: the procedure shows that it is technically possible to safely dissolve a blood clot from the retinal vein with robotic support. A Phase 2 trial now has to show what the clinical effect is for patients with retinal vein occlusion," said a spokesman for the researchers
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.